In the intricate landscape of biotechnology, the path to introducing innovative products comes with challenges that require strategic expertise. Overcoming market access and reimbursement barriers is crucial for the successful entry and adoption of transformative solutions by Biotech companies in the US market. Click here to download the document:

About the author.


20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

No Comments. Leave a comment  

Leave a Reply

Your email address will not be published. Required fields are marked *